Oncolytics Share Price

Oncolytics Share Price

NASDAQ: ONCY | Micro Cap | Healthcare
$0.35
-$0.04 (-10.05%) Last updated on 21 Nov, 2026 | 02:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Oncolytics Stock Performance

Open
$0.38
Prev. Close
$0.39
Circuit Range
N/A
Day Range
$0.34 - $0.38
Year Range
$0.34 - $1.30
Volume
19,780
Average Traded
$0.35

Oncolytics Share Price Today

As of 21 November 2026, Oncolytics Biotech, Inc.'s share price is $0.35. The stock opened at $0.38, compared to its previous close of $0.39. During today's trading session, Oncolytics Biotech, Inc.'s share price traded between $0.34 and $0.38, with an average price of $0.36. Over the past 52 weeks, the stock has recorded a high of $1.30 and a low of $0.34. In terms of performance, Oncolytics Biotech, Inc.'s share price has declined by 66.57% over the last six months and is down 64.55% on a year-on-year basis.

Oncolytics Share Price Chart

Line chart of the Oncolytics price trend over the selected period. The price fell overall, ranging from 0.34 to 0.38, ending at 0.35.
$0.34$0.38
L
Show Current Price
H

Oncolytics Stock Fundamentals & Key Indicators

Market Cap
$33.65M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.28
Revenue (TTM)
$0.00
Return On Equity (TTM)
510.04%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.72%

Oncolytics Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.88-$9.24-$9.44-$9.71
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A6.48%-2.16%-2.86%

Oncolytics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.30-$20.94-$22.79-$28.76
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.43%-8.83%-26.20%

Oncolytics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.740.990.491.22
Current Assets6.8412.4428.8126.3
Total Assets7.5813.4229.327.51
Non Current Liabilities5.285.245.35.08
Current Liabilities6.14.893.22.91
Total Liabilities11.3810.128.57.98
Shareholders' Equity-3.83.320.819.53

Oncolytics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-20.11-19.88-21.47-17.21
Investing-0.01-0.1715.26-15.04
Financing14.125.0324.158.99

About Oncolytics

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Oncolytics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.42
$0.35
-18.18%
Oct 2026
$0.63
$0.43
-35.20%
Sep 2026
$0.83
$0.66
-22.21%
Aug 2026
$0.75
$0.85
+14.08%
Jul 2026
$0.93
$0.75
-20.97%
Jun 2026
$1.16
$0.94
-10.10%
May 2026
$0.91
$1.05
+17.06%
Apr 2026
$0.85
$0.90
+5.16%
Mar 2026
$1.11
$0.85
-24.18%
Feb 2026
$0.98
$1.13
+14.21%
Jan 2026
$0.91
$0.98
+13.87%
Dec 2025
$0.99
$0.86
-12.63%

Oncolytics Share Price FAQs